Welcome to our dedicated page for Goodbdy Hlth news (Ticker: GDBYF), a resource for investors and traders seeking the latest updates and insights on Goodbdy Hlth stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Goodbdy Hlth's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Goodbdy Hlth's position in the market.
Goodbody Health Inc. reports unaudited revenue of approximately C$29 million for 2021, over 8 times higher than 2020. Despite anticipated revenue decline from PCR testing in 2022, the company generated over C$6 million in revenue in the first two months of 2022. Goodbody plans to expand its clinic network, currently at over 180 locations, to mitigate the drop in COVID testing revenue by offering blood testing and other services. Anticipated revenue dip in H1 2022 is expected to recover in the latter part of the year, closing with a solid profit.
Goodbody Health (CSE:GDBY)(OTCQB:GDBYF) has announced a significant development in its UK clinic network by ordering 100 Abbott blood testing machines to expedite blood test results in under 10 minutes. This initiative aims to address rising diabetes and cardiovascular disease rates, with more than 4.9 million people diagnosed with diabetes in the UK. The machines will be rolled out across over 150 locations, including partnerships with Superdrug, enhancing accessibility to health checks and supporting the mission to empower individuals toward healthier lifestyles.
Goodbody Health Inc. (CSE:GDBY, OTCQB:GDBYF) announced plans for a normal course issuer bid (NCIB) to repurchase up to 18,248,107 shares, representing 5% of its outstanding shares, starting from March 11, 2022, to March 10, 2023. The company believes the current share price does not reflect its underlying value. Additionally, a restricted share unit plan (RSU Plan) has been approved to align interests of executives with shareholders, allowing grants of RSUs up to 10% of issued shares.
Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) has upgraded its listing from the OTC pink market to the OTCQB market as of February 22, 2022. This move reflects the company's improved governance and aims to attract larger investors, thereby enhancing shareholder value. The OTCQB platform is noted for providing reliable public information and facilitates trading through preferred brokers. Executive Chairman Geremy Thomas expressed optimism about being part of a regulated market that benefits US investors.
Goodbody Health Inc. announces the lease signing for its first clinic in Vancouver, Canada, following a successful launch of clinics in the UK. The clinic is located in the Burrard Health Centre, ideal for future expansion opportunities. Executive Chairman Geremy Thomas expressed optimism about replicating the UK success in Canada. The announcement highlights Goodbody's strategy to broaden its footprint in North America.
Goodbody Health (CSE:GDBY) is rolling out a new blood testing initiative across its clinics, including in-clinic phlebotomy services. This expansion involves the establishment of a phlebotomy training academy for staff and aims to deliver rapid health tests for cholesterol and diabetes. The company continues to report strong COVID testing revenues, averaging over 500 tests daily, despite eased UK restrictions. Executive Chairman Geremy Thomas noted that partners are eager to adopt this model, which enhances local healthcare access while maintaining PCR testing services.
Goodbody Health Inc. has announced a change in its over-the-counter market (OTC) ticker in the United States, moving from SCNFF to GDBYF. The update will take effect at 0:00 a.m. EST on February 3, 2022. The company’s directors are responsible for the announcement's content, as stated. This change is significant for investors tracking Goodbody Health's trading performance in the OTC market.
FAQ
What is the current stock price of Goodbdy Hlth (GDBYF)?
What is the market cap of Goodbdy Hlth (GDBYF)?
